Morphologic prognostic factors of malignant mixed müllerian tumors of the ovary: a clinicopathologic study of 15 casesBOUCHER, D; TETU, B.International journal of gynecological pathology. 1994, Vol 13, Num 1, pp 22-28, issn 0277-1691Article

Ovarian metastases of breast carcinoma: a clinicopathologic study of 59 casesGAGNON, Y; TETU, B.Cancer. 1989, Vol 64, Num 4, pp 892-898, issn 0008-543X, 7 p.Article

EFFECTS OF NORADRENALINE AND NICOTINIC ACID ON PLASMA FREE FATTY ACIDS AND OXYGEN CONSUMPTION IN COLD-ADAPTED RATSLAFRANCE L; ROUTHIER D; TETU B et al.1979; CANAD. J. PHYSIOL. PHARMACOL.; CAN; DA. 1979; VOL. 57; NO 7; PP. 725-730; ABS. FRE; BIBL. 37 REF.Article

Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer : the influence of the pattern of immunostaining and adjuvant therapyTETU, B; BRISSON, J.Cancer. 1994, Vol 73, Num 9, pp 2359-2365, issn 0008-543XArticle

Analyse et suivi des investissements dans une entrepriseTETU, B.1984, 54 p.Thesis

Ovarian myxoma : a study of two cases with long-term follow-upTETU, B; BONENFANT, J.-L.American journal of clinical pathology. 1991, Vol 95, Num 3, pp 340-346, issn 0002-9173Article

Prognostic significance of heat-shock protein-27 in node-positive breast carcinoma : an immunohistochemical studyTETU, B; BRISSON, J; LANDRY, J et al.Breast cancer research and treatment. 1995, Vol 36, Num 1, pp 93-97, issn 0167-6806Article

High levels of P-glycoprotein detected in isolated brain capillariesJETTE, L; TETU, B; BELIVEAU, R et al.Biochimica et biophysica acta. Biomembranes. 1993, Vol 1150, Num 2, pp 147-154, issn 0005-2736Article

Prognostic significance of tumor DNA content and S-phase fraction by flow cytometry in node-positive breast carcinomasTETU, B; BRISSON, J; ROBERGE, N et al.The Cancer journal (Print). 1993, Vol 6, Num 6, pp 322-329, issn 0765-7846Article

Renin-producing ovarian tumor. A case report with immunohistochemical and electron-microscopic studyTETU, B; LEBEL, M; CAMILLERI, J.-P et al.The American journal of surgical pathology. 1988, Vol 12, Num 8, pp 634-640, issn 0147-5185Article

Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancerTETU, B; BRISSON, J; LAPOINTE, H et al.Human pathology. 1998, Vol 29, Num 9, pp 979-985, issn 0046-8177Article

Tumeur rénale à sécrétion de rénine. A propos d'un cas avec étude ultrastructurale et immunohistochimique = Renal tumor with renin secretion. One case with ultrastructural and immunohistochemical studyTETU, B; TOTOVIC, V; BECHTELSHEIMER, H et al.Annales de pathologie (Paris). 1984, Vol 4, Num 1, pp 55-59, issn 0242-6498Article

The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic indexALLARD, P; BERNARD, P; FRADET, Y et al.British journal of urology (Print). 1998, Vol 81, Num 5, pp 692-698, issn 0007-1331Article

Large cell calcifying sertoli cell tumor of the testis : a clinicopathologic, immunohistochemical, and ultrastructural study of two casesTETU, B; RO, J. Y; AYALA, A. G et al.American journal of clinical pathology. 1991, Vol 96, Num 6, pp 717-722, issn 0002-9173Article

Squamous cell carcinoma of the ovaryTETU, B; SILVA, E. G; GERSHENSON, D. M et al.Archives of pathology & laboratory medicine (1976). 1987, Vol 111, Num 9, pp 864-866, issn 0363-0153Article

Sertoli-Leydig cell tumor of the ovary with α-fetoprotein productionTETU, B; ORDONEZ, N. G; SILVA, E. G et al.Archives of pathology & laboratory medicine (1976). 1986, Vol 110, Num 1, pp 65-68, issn 0363-0153Article

Persistence of high-grade prostatic intra-epithelial neoplasia under combined androgen blockade therapyVAN DER KWAST, T. H; LABRIE, F; TETU, B et al.Human pathology. 1999, Vol 30, Num 12, pp 1503-1507, issn 0046-8177Article

Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypesPFISTER, C; LARUE, H; MOORE, L et al.International journal of cancer. 2000, Vol 89, Num 1, pp 100-104, issn 0020-7136Article

Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrencePFISTER, C; MOORE, L; ALLARD, P et al.Clinical cancer research. 1999, Vol 5, Num 12, pp 4079-4084, issn 1078-0432Article

Neoadjuvant hormonal therapy : The Canadian experienceLABRIE, F; CUSAN, L; GOMEZ, J.-L et al.Urology (Ridgewood, NJ). 1997, Vol 49, Num 3A, pp 56-64, issn 0090-4295, SUPConference Paper

The molecular basis of Turcot's syndromeHAMILTON, S. R; BO LIU; BURGER, P. C et al.The New England journal of medicine. 1995, Vol 332, Num 13, pp 839-847, issn 0028-4793Article

La biopsie prostatique transrectale sous guide ultrasonore = Transrectal biopsy of the prostate guided with transrectal ultrasoundPINAULT, S; FORTIN, D; GAGNON, J et al.Radiologie (Berlin). 1990, Vol 10, Num 5, pp 313-317, issn 0720-3322Article

Small cell carcinoma of prostate associated with myasthenic (Eaton-Lambert) syndromeTETU, B; RO, J. Y; AYALA, A. G et al.Urology (Ridgewood, NJ). 1989, Vol 33, Num 2, pp 148-152, issn 0090-4295Article

Blue nevus and melanosis of the prostateRO, J. Y; GRIGNON, D. J; AYALA, A. G et al.American journal of clinical pathology. 1988, Vol 90, Num 5, pp 530-535, issn 0002-9173Article

Small cell carcinoma of the kidney: a clinicopathologic, immunohistochemical, and ultrastructural studyTETU, B; RO, J. Y; AYALA, A. G et al.Cancer. 1987, Vol 60, Num 8, pp 1809-1814, issn 0008-543XArticle